Search

Your search keyword '"Eliana Di Fiore"' showing total 3 results
Start Over Author "Eliana Di Fiore"
3 results on '"Eliana Di Fiore"'

1. Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?

Author

Monica Lamberti, Alfredo De Rosa, Elpidio Maria Garzillo, Anna Rita Corvino, Nicola Sannolo, Stefania De Pascalis, Eliana Di Fiore, Claudia Westermann, Antonio Arnese, Di Giuseppe Gabriella, Albert Nienhaus, Antônio Paulino Ribeiro Sobrinho, Nicola Coppola, Lamberti, Monica, DE ROSA, Alfredo, Garzillo, Elpidio Maria, Corvino, Anna Rita, Sannolo, Nicola, De Pascalis, Stefania, Di Fiore, Eliana, Westermann, Claudia, Arnese, Antonio, DI GIUSEPPE, Gabriella, Nienhaus, Albert, Sobrinho, Antônio Paulino Ribeiro, and Coppola, Nicola

Subjects
Healthcare students, Research, Anti-HBs titre, Public Health, Environmental and Occupational Health, virus diseases, Healthcare student, Erratum, Toxicology, Safety Research, digestive system diseases, HBV infection, HBV vaccination
Abstract

The development of a vaccine against hepatitis B virus (HBV) has been a major achievement in terms of prevention of HBV infection. For the present study, we analysed the long-term immunogenicity and effectiveness of HBV vaccination among healthcare students with different working seniorities. Background: The development of a vaccine against hepatitis B virus (HBV) has been a major achievement in terms of prevention of HBV infection. For the present study, we analysed the long-term immunogenicity and effectiveness of HBV vaccination among healthcare students with different working seniorities. Methods: A cross-sectional study of undergraduate and postgraduate students attending the Medical School of the Second University of Naples was conducted between September 2012 and December 2014. HBV serum markers were determined and multivariate logistic regression analysis was used to identify factors associated with the level of long-term immunogenicity. Results: Of the 2,932 subjects evaluated, only 33 (1.1 %) declared no history of vaccination. All vaccinated subjects were HBsAg/anti-HBc negative, 459 of which had an anti-HBs titre

Published
2015

2. The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy

Author

Eliana Di Fiore, Albert Nienhaus, Stefania De Pascalis, Giuseppe Signoriello, Anna Rita Corvino, Evangelista Sagnelli, Nicola Coppola, Monica Lamberti, Coppola, Nicola, Corvino, Anna Rita, De Pascalis, Stefania, Signoriello, Giuseppe, Di Fiore, Eliana, Nienhaus, Albert, Sagnelli, Evangelista, and Lamberti, Monica

Subjects
Adult, Male, Pediatrics, medicine.medical_specialty, HBsAg, Logistic Model, Booster dose, medicine.disease_cause, Hepatitis B Antibodie, Healthcare students, Medical microbiology, Retrospective Studie, medicine, Humans, Hepatitis B Vaccines, Hepatitis B Antibodies, Child, HBV infection, HBV vaccination, Retrospective Studies, Hepatitis B virus, Vaccines, Synthetic, business.industry, Immunogenicity, Infant, Newborn, Biomarker, Hepatitis B Vaccine, Hepatitis B, medicine.disease, Anti-HBs titer, Vaccination, Titer, Infectious Diseases, Logistic Models, Italy, Immunology, Healthcare student, Female, business, Biomarkers, Human, Research Article
Abstract

Background Universal hepatitis B virus (HBV) vaccination of newborn babies was introduced in Italy in 1991 and was extended to 12-years-old children for the first 12 years of application so as to cover in a dozen years the Italian population aged 0-24 years. The aim of this study was to identify factors associated with long-term immunogenicity against HBV 17 years after primary vaccination in students attending medical schools in Naples, Italy. Methods 1,704 students attending the school of medicine, schools of the healthcare professions, or postgraduate medical schools of the Second University of Naples, Italy, from September 2012 to December 2013 were enrolled in this study. Of these, 588 had been vaccinated against HBV in infancy and 1,116 when 12 years old. Multivariate logistic regression analysis was used to identify factors associated with the level of long-term immunogenicity. Results All vaccinated subjects were HBsAg/anti-HBc negative: 270 (15.8%) had an anti-HBs titer between 1 and 9 IU/L, 987 (57.9%) between 10 and 400 IU/L, and 447 (26.3%) over 400 IU/L. When compared with the latter two subgroups, those with anti-HBs titers lower than 10 IU/L were younger (24 ± 5.2 years vs. 26 ± 4.9 years, p

Published
2015

3. Erratum to: Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?

Author

Nicola Sannolo, Antonio Arnese, Anna Rita Corvino, Elpidio Maria Garzillo, Albert Nienhaus, Nicola Coppola, Claudia Westermann, Eliana Di Fiore, Antônio Paulino Ribeiro Sobrinho, Alfredo De Rosa, Stefania De Pascalis, Gabriella Di Giuseppe, and Monica Lamberti

Subjects
Hepatitis B virus, medicine.medical_specialty, HBsAg, business.industry, Immunogenicity, Public health, Public Health, Environmental and Occupational Health, Hepatitis B, medicine.disease, medicine.disease_cause, Toxicology, digestive system diseases, Vaccination, Immunization, Family medicine, Immunology, medicine, Viral hepatitis, business, Safety Research
Abstract

The development of a vaccine against hepatitis B virus (HBV) has been a major achievement in terms of prevention of HBV infection. For the present study, we analysed the long-term immunogenicity and effectiveness of HBV vaccination among healthcare students with different working seniorities. A cross-sectional study of undergraduate and postgraduate students attending the Medical School of the Second University of Naples was conducted between September 2012 and December 2014. HBV serum markers were determined and multivariate logistic regression analysis was used to identify factors associated with the level of long-term immunogenicity. Of the 2,932 subjects evaluated, only 33 (1.1 %) declared no history of vaccination. All vaccinated subjects were HBsAg/anti-HBc negative, 459 of which had an anti-HBs titre

Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results